Nektar Therapeutics Strategic Asset Allocation Index
Nektar Therapeutics strategic asset allocation index. Nektar Therapeutics (NKTR) has a Strategic Asset Allocation Index of 37.7% as of June 2026. Strategic assets (PP&E of $- plus long-term investments of $340.48 Million) total $340.48 Million, measured against net assets of $903.12 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Nektar Therapeutics net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Nektar Therapeutics (2000–2025)
Strategic asset allocation index of Nektar Therapeutics from 2000 to 2025. This chart shows how Nektar Therapeutics's Strategic Asset Allocation Index has evolved across 25 annual periods from 2000 to 2025. As of June 2026, the index stands at 37.7%, representing strategic assets of $340.48 Million against net assets of $903.12 Million USD. Check Nektar Therapeutics (NKTR) tangible net worth to evaluate the tangible quality of the company's equity base.
Nektar Therapeutics Strategic Asset Allocation Index by Year (2000–2025)
Nektar Therapeutics strategic asset allocation index by year from 2000 to 2025. The table below presents the year-by-year Strategic Asset Allocation Index for Nektar Therapeutics from 2000 to 2025, covering 25 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Nektar Therapeutics market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 3.9% | $3.49 Million | $- | $3.49 Million | $89.83 Million | ▼ -39.1 pp |
| 2024 | 43.0% | $26.09 Million | $- | $26.09 Million | $60.74 Million | ▲ +23.2 pp |
| 2023 | 19.7% | $25.82 Million | $- | $25.82 Million | $130.99 Million | ▼ -3.7 pp |
| 2022 | 23.4% | $85.89 Million | $85.89 Million | $0.00 | $366.64 Million | ▼ -12.2 pp |
| 2021 | 35.7% | $242.36 Million | $177.53 Million | $64.83 Million | $679.51 Million | ▲ +17.4 pp |
| 2020 | 18.2% | $196.32 Million | $59.66 Million | $136.66 Million | $1.08 Billion | ▼ -6.3 pp |
| 2019 | 24.5% | $344.12 Million | $65.00 Million | $279.12 Million | $1.41 Billion | ▼ -12.3 pp |
| 2018 | 36.8% | $631.74 Million | $48.85 Million | $582.89 Million | $1.72 Billion | ▼ -82.3 pp |
| 2017 | 119.0% | $104.55 Million | $47.46 Million | $57.09 Million | $87.83 Million | ▲ +44.6 pp |
| 2016 | 74.4% | $65.60 Million | $65.60 Million | $- | $88.12 Million | ▼ -1035.2 pp |
| 2015 | 1109.6% | $71.34 Million | $71.34 Million | $- | $6.43 Million | ▲ +915.9 pp |
| 2014 | 193.7% | $70.37 Million | $70.37 Million | $- | $36.33 Million | ▲ +40.1 pp |
| 2012 | 153.6% | $72.22 Million | $72.22 Million | $- | $47.02 Million | ▲ +26.0 pp |
| 2011 | 127.6% | $252.34 Million | $78.58 Million | $173.77 Million | $197.81 Million | ▲ +28.5 pp |
| 2010 | 99.0% | $89.77 Million | $89.77 Million | $- | $90.66 Million | ▲ +22.6 pp |
| 2009 | 76.5% | $78.26 Million | $78.26 Million | $- | $102.37 Million | ▲ +37.8 pp |
| 2008 | 38.7% | $73.58 Million | $73.58 Million | $- | $190.15 Million | ▼ -14.7 pp |
| 2007 | 53.4% | $114.42 Million | $114.42 Million | $- | $214.44 Million | ▼ -5.6 pp |
| 2006 | 58.9% | $133.81 Million | $133.81 Million | $- | $227.06 Million | ▲ +15.4 pp |
| 2005 | 43.5% | $142.13 Million | $142.13 Million | $- | $326.81 Million | ▲ +11.1 pp |
| 2004 | 32.4% | $151.25 Million | $151.25 Million | $- | $467.34 Million | ▼ -58.6 pp |
| 2003 | 91.0% | $149.39 Million | $149.39 Million | $- | $164.19 Million | ▲ +21.6 pp |
| 2002 | 69.4% | $143.45 Million | $143.45 Million | $- | $206.77 Million | ▲ +16.7 pp |
| 2001 | 52.7% | $142.35 Million | $142.35 Million | $- | $270.31 Million | ▲ +12.9 pp |
| 2000 | 39.7% | $110.46 Million | $110.46 Million | $- | $277.88 Million | — |